Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 5

Sponsor Class

OTHER 38INDUSTRY 33NIH 5NETWORK 2FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 4Gynecologic 1

Conditions

Melanoma 2Carcinoma, Basal Cell 2Uterine Cervical Dysplasia 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × NIH × Imiquimod × Clear all
NCT03196180 2025-04-08

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Completed
13 enrolled 10 charts
Gynecologic

Uterine Cervical Dysplasia

NCT00453050 2015-05-06

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

National Cancer Institute (NCI)

Phase 1 Completed
11 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

NCT00066872 2013-09-17

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

National Cancer Institute (NCI)

Phase 3 Completed
500 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00079300 2013-04-26

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
Dermatologic

Carcinoma, Basal Cell

NCT00273910 2012-10-19

Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
104 enrolled 12 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡